Posted in | News | Biomaterials

US Patent Awarded for Biomerix Biomaterial Platform Technology

Biomerix Corporation today announced that the United States Patent and Trademark Office (USPTO) has granted a patent for its proprietary biomaterial platform technology titled "Reticulated elastomeric matrices, their manufacture and use in implantable devices."

The Company's platform technology, the Biomerix Biomaterial™ is a non-resorbable reticulated, polycarbonate polyurethane-urea, consisting of an open-cell, three-dimensional, interconnected tissue scaffold. The novel structure of the biomaterial translates into an ability to support predictable, organized fibrovascular tissue ingrowth and remodeling.

The Biomerix Biomaterial is designed to play a role similar to the body's extracellular matrix (ECM), through the main phases of inflammation, proliferation, and remodeling.  Benefits of the Biomerix Biomaterial extend beyond medical device applications. The material's unique structure and chemistry impart differentiated benefits including high porosity, excellent resilience, long-term durability and superior chemical compatibility over current polymeric materials. It is these advantages that make the Biomerix Biomaterial a compelling alternative for potential industrial and consumer applications.

"Biomerix secured one of its most important intellectual property assets representing a significant milestone for our company and is the culmination of extensive research and development," stated Kenneth G. Hayes, President and Chief Executive Officer of Biomerix Corporation. "The scope of this technology is far reaching and has the potential to drive technological innovation across a broad spectrum of applications in the medical, industrial, and consumer industries."

The US patent number is 7,803,395.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.